Stockscreener 앱 받기
5.07
0.20%
0.01
시간 외 거래:
5.07
전일 마감가:
$5.06
열려 있는:
$5.13
하루 거래량:
206.81K
Relative Volume:
0.40
시가총액:
$276.95M
수익:
$163.78M
순이익/손실:
$25.88M
주가수익비율:
7.80
EPS:
0.65
순현금흐름:
$-28.66M
1주 성능:
-6.97%
1개월 성능:
-18.88%
6개월 성능:
-41.92%
1년 성능:
-30.55%
1일 변동 폭
$5.05
$5.145
1주일 범위
$4.99
$5.45
52주 변동 폭
$4.99
$10.66
Voyager Therapeutics Inc Stock (VYGR) Company Profile
명칭
Voyager Therapeutics Inc
전화
857-259-5340
주소
75 HAYDEN AVENUE, LEXINGTON, MA
VYGR을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
VYGR
Voyager Therapeutics Inc
|
5.07 | 276.95M | 163.78M | 25.88M | -28.66M | 0.65 |
|
VRTX
Vertex Pharmaceuticals Inc
|
422.00 | 108.68B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
681.58 | 74.90B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
640.52 | 38.30B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
246.27 | 31.76B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
111.93 | 26.83B | 3.30B | -501.07M | 1.03B | -2.1146 |
Voyager Therapeutics Inc Stock (VYGR) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-01-10 | 개시 | Cantor Fitzgerald | Overweight |
| 2024-12-02 | 개시 | Citigroup | Buy |
| 2024-11-29 | 재개 | Wedbush | Outperform |
| 2024-10-16 | 개시 | Leerink Partners | Outperform |
| 2024-03-26 | 개시 | Guggenheim | Buy |
| 2024-03-19 | 개시 | H.C. Wainwright | Buy |
| 2024-03-07 | 개시 | Citigroup | Buy |
| 2024-01-02 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2023-05-10 | 개시 | Truist | Buy |
| 2023-03-10 | 개시 | Oppenheimer | Outperform |
| 2021-10-07 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2021-02-26 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2021-02-03 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2021-02-03 | 다운그레이드 | Wedbush | Outperform → Neutral |
| 2020-12-24 | 다운그레이드 | Cantor Fitzgerald | Overweight → Neutral |
| 2020-12-23 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2020-11-11 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2020-11-10 | 다운그레이드 | Raymond James | Strong Buy → Outperform |
| 2020-11-10 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2020-03-19 | 개시 | The Benchmark Company | Buy |
| 2020-02-06 | 개시 | Oppenheimer | Outperform |
| 2018-11-15 | 업그레이드 | Raymond James | Outperform → Strong Buy |
| 2018-09-10 | 재개 | BTIG Research | Buy |
| 2018-09-10 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2018-06-04 | 개시 | H.C. Wainwright | Buy |
| 2018-03-12 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2018-03-12 | 다운그레이드 | Wedbush | Outperform → Neutral |
| 2018-02-02 | 개시 | Morgan Stanley | Overweight |
| 2017-11-28 | 재개 | Piper Jaffray | Overweight |
| 2017-10-31 | 개시 | Robert W. Baird | Outperform |
| 2017-10-27 | 개시 | Canaccord Genuity | Buy |
| 2017-10-23 | 재확인 | Stifel | Buy |
| 2017-10-12 | 개시 | Raymond James | Outperform |
| 2017-08-17 | 개시 | Evercore ISI | Outperform |
| 2017-07-28 | 재개 | Stifel | Buy |
모두보기
Voyager Therapeutics Inc 주식(VYGR)의 최신 뉴스
Is it a Good Idea to Invest in Stoke Therapeutics Stock Now? - Yahoo Finance
Barclays PLC Grows Stock Position in Voyager Therapeutics, Inc. (NASDAQ:VYGR) - Defense World
Insider Sell: Robin Swartz Sells Shares of Voyager Therapeutics Inc - GuruFocus.com
Voyager Therapeutics COO Robin Swartz sells $15,712 in stock By Investing.com - Investing.com South Africa
Voyager Therapeutics, Inc. (NASDAQ:VYGR) COO Sells $15,712.83 in Stock - MarketBeat
Voyager Therapeutics chief scientific officer sells shares worth $6,109 - Investing.com
Cantor Fitzgerald Predicts VYGR FY2024 Earnings - Defense World
Analysts Issue Forecasts for VYGR FY2024 Earnings - MarketBeat
Even though Voyager Therapeutics (NASDAQ:VYGR) has lost US$40m market cap in last 7 days, shareholders are still up 80% over 3 years - Simply Wall St
Voyager Therapeutics stock hits 52-week low at $5.18 By Investing.com - Investing.com Canada
Voyager Therapeutics stock hits 52-week low at $5.18 - Investing.com India
Cantor Fitzgerald Begins Coverage on Voyager Therapeutics (NASDAQ:VYGR) - Defense World
Voyager Therapeutics, Inc. (NASDAQ:VYGR) Given Consensus Recommendation of "Buy" by Analysts - MarketBeat
Voyager Therapeutics, Inc. (NASDAQ:VYGR) Given Consensus Rating of “Buy” by Brokerages - Defense World
Cantor Fitzgerald Initiates Coverage of Voyager Therapeutics (VYGR) with Overweight Recommendation - MSN
Voyager Therapeutics (NASDAQ:VYGR) Coverage Initiated by Analysts at Cantor Fitzgerald - MarketBeat
Trend Tracker for (VYGR) - Stock Traders Daily
Jane Street Group LLC Lowers Stock Holdings in Voyager Therapeutics, Inc. (NASDAQ:VYGR) - Defense World
Jane Street Group LLC Cuts Holdings in Voyager Therapeutics, Inc. (NASDAQ:VYGR) - MarketBeat
Voyager Therapeutics, Inc. (NASDAQ:VYGR) Shares Purchased by Geode Capital Management LLC - Defense World
Barclays PLC Boosts Stock Holdings in Voyager Therapeutics, Inc. (NASDAQ:VYGR) - Defense World
Voyager Therapeutics, Inc. (NASDAQ:VYGR) Shares Sold by State Street Corp - Defense World
Voyager Therapeutics, Inc. (NASDAQ:VYGR) Position Reduced by State Street Corp - MarketBeat
Voyager Therapeutics, Inc. (VYGR): Is This Gene Therapy Stock a Good Buy Right Now? - Yahoo Finance
How to Take Advantage of moves in (VYGR) - Stock Traders Daily
Voyager Therapeutics COO Robin Swartz sells shares worth $36,725 By Investing.com - Investing.com Australia
Voyager Therapeutics COO Robin Swartz sells shares worth $36,725 - Investing.com India
Robin Swartz Sells 6,500 Shares of Voyager Therapeutics, Inc. (NASDAQ:VYGR) Stock - MarketBeat
Insider Sell: Robin Swartz Sells 6,500 Shares of Voyager Therape - GuruFocus.com
Should Weakness in Voyager Therapeutics, Inc.'s (NASDAQ:VYGR) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials? - Simply Wall St
Charles Schwab Investment Management Inc. Buys 3,473 Shares of Voyager Therapeutics, Inc. (NASDAQ:VYGR) - Defense World
Voyager Therapeutics, Inc. (NASDAQ:VYGR) Shares Bought by Fmr LLC - Defense World
Long Term Trading Analysis for (VYGR) - Stock Traders Daily
3 Biotech Stocks With Promising Gene Therapies to Watch Out in 2025 - Yahoo Finance
Voyager Therapeutics, Inc. (NASDAQ:VYGR) Receives $17.00 Consensus PT from Brokerages - MarketBeat
BNP Paribas Financial Markets Has $288,000 Stake in Voyager Therapeutics, Inc. (NASDAQ:VYGR) - Defense World
Verition Fund Management LLC Purchases New Position in Voyager Therapeutics, Inc. (NASDAQ:VYGR) - Defense World
StockNews.com Downgrades Voyager Therapeutics (NASDAQ:VYGR) to Hold - Defense World
Voyager Therapeutics (NASDAQ:VYGR) Downgraded by StockNews.com to Hold - MarketBeat
Voyager Therapeutics up 8% following quarterly beats - Seeking Alpha
Institutional investors own a significant stake of 48% in Voyager Therapeutics, Inc. (NASDAQ:VYGR) - Yahoo Finance
(VYGR) Trading Signals - Stock Traders Daily
Wall Street Analysts See a 152.53% Upside in Voyager Therapeutics (VYGR): Can the Stock Really Move This High? - MSN
Erste Asset Management GmbH Purchases Shares of 1,058,378 Voyager Therapeutics, Inc. (NASDAQ:VYGR) - MarketBeat
Voyager Therapeutics (NASDAQ:VYGR) Now Covered by Citigroup - Defense World
Voyager Therapeutics shares initiated with Buy rating by Citi, strong gene therapy pipeline - Investing.com Canada
A Glimpse Into The Expert Outlook On Voyager Therapeutics Through 5 Analysts - Benzinga
Voyager Therapeutics, Inc. (NASDAQ:VYGR) Short Interest Update - Defense World
Wedbush assumes coverage of Voyager with outperform rating - MSN
Voyager Therapeutics (NASDAQ:VYGR) Earns Outperform Rating from Analysts at Wedbush - MarketBeat
Wedbush upgrades Voyager to Outperform on pipeline progress - Yahoo Finance
Voyager Therapeutics Inc (VYGR) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.65%
4.62%
자본화:
|
볼륨(24시간):